Mayara Costa de Camargo

Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting

Mayara Costa de Camargo, Bruna Cipriano Almeida Barros, Izabela Fulone et al. · Frontiers in Pharmacology · 2019 · 42 citations · Full text

Efficacy and costs of nanocrystalline silver dressings versus 1% silver sulfadiazine dressings to treat burns in adults in the outpatient setting: A randomized clinical trial

Silvia Silva Moreira, Mayara Costa de Camargo, Rosângela Caetano et al. · Burns · 2021 · 20 citations

Randomized Clinical Trial, Outpatient Setting, Nanocrystalline Silver Dressings +5

Adherence to guidelines in the use of biological agents to treat psoriasis in Brazil

Miriam Sanches do Nascimento Silveira, Iara Alves de Camargo, Cláudia Garcia Serpa Osorio-de-Castro et al. · BMJ Open · 2014 · 13 citations · Full text

Patient reports of the frequency and severity of adverse reactions associated with biological agents prescribed for psoriasis in Brazil

Luciane Cruz Lopes, Miriam Sanches do Nascimento Silveira, Mayara Costa de Camargo et al. · Expert Opinion on Drug Safety · 2014 · 12 citations